YD Bio Ltd (YDES)Healthcare | Biotechnology | Taipei, Taiwan | NasdaqGM
4.80 USD
+0.93
(24.031%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 4.23 -0.57 (-0.570%) ⇩ (Aug. 28, 2026, 7:03 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:55 a.m. EDT
The immediate outlook is severely clouded by a statistically weak forecast predicting a nearly 18% drop over the next 45 days, compounded by a recent price collapse from $13.36 to $4.69—a 65% drawdown that suggests the market is aggressively repricing the business. While the company boasts a massive 95.6% revenue growth and a pristine balance sheet with negligible debt relative to its tiny market cap, these fundamentals are currently overshadowed by the reality of negative earnings, negative free cash flow, and a valuation that is absurdly detached from profitability (P/S of 650x). The lack of any dividend history confirms this is a pure speculative vehicle with no income floor. Until the path to profitability becomes clear and the stock stabilizes above its recent lows, the risk-reward profile remains skewed heavily toward further downside. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.147999 |
| MSTL | 0.151965 |
| AutoTheta | 0.423136 |
| AutoARIMA | 0.453449 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 20% |
| H-stat | 9.92 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.05 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.338 |
| Revenue per Share | 0.466 |
| Market Cap | 339,990,464 |
| Beta | -0.13 |
| Profit Margins | -276.58% |
| Previous Name | Breeze Holdings Acquisition Corp. |
| Website | https://www.ydesgroup.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7164835 |
| Address1 | No. 3, Xingnan St. |
| Address2 | 12F. Nangang Dist. |
| All Time High | 25.0 |
| All Time Low | 1.7 |
| Ask | 2.38 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 51,650 |
| Average Daily Volume3 Month | 141,091 |
| Average Volume | 141,091 |
| Average Volume10Days | 51,650 |
| Beta | -0.131 |
| Bid | 2.27 |
| Bid Size | 1 |
| Book Value | 4.571 |
| City | Taipei |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.8 |
| Current Ratio | 13.183 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 4.8 |
| Day Low | 3.09 |
| Debt To Equity | 0.338 |
| Display Name | YD Bio |
| Ebitda | -1,357,195 |
| Ebitda Margins | -2.6592898 |
| Enterprise To Ebitda | -1.82 |
| Enterprise To Revenue | 4.839 |
| Enterprise Value | 2,469,601 |
| Eps Trailing Twelve Months | -0.12 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.69338 |
| Fifty Day Average Change | 2.10662 |
| Fifty Day Average Change Percent | 0.78214735 |
| Fifty Two Week Change Percent | -71.648346 |
| Fifty Two Week High | 25.0 |
| Fifty Two Week High Change | -20.2 |
| Fifty Two Week High Change Percent | -0.808 |
| Fifty Two Week Low | 1.7 |
| Fifty Two Week Low Change | 3.1000001 |
| Fifty Two Week Low Change Percent | 1.8235295 |
| Fifty Two Week Range | 1.7 - 25.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,756,215,000,000 |
| Float Shares | 322,235 |
| Free Cashflow | -3,875,569 |
| Full Exchange Name | NasdaqGM |
| Fullday Change | 0.93 |
| Fullday Change Percent | 24.031 |
| Fullday Price | 4.23 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.3044 |
| Gross Profits | 155,356 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.80132 |
| Held Percent Institutions | 0.00399 |
| Implied Shares Outstanding | 70,831,346 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-08-29 |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Long Business Summary | YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. |
| Long Name | YD Bio Ltd |
| Market | us_market |
| Market Cap | 339,990,464 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1898493574 |
| Most Recent Quarter | 1,735,603,200 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -1,411,559 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 274,117,309 |
| Open | 3.94 |
| Operating Cashflow | -1,836,818 |
| Operating Margins | -4.44588 |
| Payout Ratio | 0.0 |
| Post Market Change | -0.5700002 |
| Post Market Change Percent | -11.875003 |
| Post Market Price | 4.23 |
| Post Market Time | 1,787,958,209 |
| Prev Name | Breeze Holdings Acquisition Corp. |
| Previous Close | 3.87 |
| Price Hint | 4 |
| Price To Book | 1.0500984 |
| Price To Sales Trailing12 Months | 666.17773 |
| Profit Margins | -2.76581 |
| Quick Ratio | 12.906 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.93 |
| Regular Market Change Percent | 24.031 |
| Regular Market Day High | 4.8 |
| Regular Market Day Low | 3.09 |
| Regular Market Day Range | 3.09 - 4.8 |
| Regular Market Open | 3.94 |
| Regular Market Previous Close | 3.87 |
| Regular Market Price | 4.8 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 217,668 |
| Return On Assets | -0.25432 |
| Return On Equity | -0.42689 |
| Revenue Growth | 0.956 |
| Revenue Per Share | 0.466 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 70,831,346 |
| Shares Percent Shares Out | 0.0002 |
| Shares Short | 17,167 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 25,094 |
| Short Name | YD Bio Limited |
| Short Percent Of Float | 0.001 |
| Short Ratio | 0.47 |
| Source Interval | 15 |
| Symbol | YDES |
| Total Cash | 3,132,298 |
| Total Cash Per Share | 2.173 |
| Total Debt | 22,265 |
| Total Revenue | 510,360 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.12 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.95847 |
| Two Hundred Day Average Change | -2.1584697 |
| Two Hundred Day Average Change Percent | -0.31019315 |
| Type Disp | Equity |
| Volume | 217,668 |
| Website | https://www.ydesgroup.com |
| Zip | 115,001 |